DOI: http://dx.doi.org/10.18203/2349-3291.ijcp20202637

Utility of brain natriuretic peptide in the neonatal pathologies

Shriprasad R. Deshpande

Abstract


This is with reference to the recently published article titled ‘N-terminal pro brain natriuretic peptide as a marker of myocardial dysfunction in newborns with perinatal asphyxia’ by Drs. Kariyappa et al.

Full Text:

PDF

References


Kariyappa M, Shivarudrappa S. N-terminal pro brain natriuretic peptide as a marker of myocardial dysfunction in newborns with perinatal asphyxia. Int J Contemp Pediatr 2020;7:997-1002.

Jain D, Pandey AK, Das BK, Prasad R. Cardiac Function in Perinatal Asphyxia. Sch J App Med Sci. 2016;4(7):2718-28

Simovic AM, Kosutic JL, Prijic SM, Knezevic JB, Vujic AJ, Stojanovic ND. The role of biochemical markers as early indicators of cardiac damage and prognostic parameters of perinatal asphyxia. Vojnosanitetski pregled. 2014;71(2):149-55.

Reynolds EW, Ellington JG, Vranicar M, Bada HS. Brain-type natriuretic peptide in the diagnosis and management of persistent pulmonary hypertension of the newborn Pediatrics. 2004;114(5):1297-304.

Popescu MR, Panaitescu AM, Pavel B, Zagrean L, Peltecu G, Zagrean AM. Getting an Early Start in Understanding Perinatal Asphyxia Impact on the Cardiovascular System. Front Pediatr. 2020;8:68.